Overexpression of miR-125b-5p protected skeletal muscle samples from atrophy both in vitro and in vivo by targeting TRAF6 through the inactivation of several ubiquitin–proteasome system (UPS)- and autophagy–lysosome system (ALS)-related proteins [40]. The gene discussed is TRAF6; the disease is amyotrophic lateral sclerosis.